StageZero Life Sciences Ltd

TSX:SZLS (Canada)  
C$ 0.04 (0%) Apr 22
At Loss
Market Cap:
C$ 4.91M ($ 3.58M)
Enterprise V:
C$ 6.74M ($ 4.92M)
Volume:
-
Avg Vol (2M):
112.18K
Also Trade In:

Business Description

Description
StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.02
Equity-to-Asset -17.87
Debt-to-Equity -0.15
Debt-to-EBITDA -0.11
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -440.58
Distress
Grey
Safe
Beneish M-Score -48.63
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 34.7
9-Day RSI 41.3
14-Day RSI 44.25
6-1 Month Momentum % 28.57
12-1 Month Momentum % -43.75

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.04
Quick Ratio 0.03
Days Inventory 12.7
Days Sales Outstanding 7.38
Days Payable 371.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -45.9
Shareholder Yield % -15.89

Profitability Rank

Name Current Vs Industry Vs History
Gross Margin % 0.25
Operating Margin % -154.03
Net Margin % -420.86
FCF Margin % -27.71
ROA % -574.18
ROIC % -149.29
ROC (Joel Greenblatt) % -3214.62

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 1.11
EV-to-EBIT -0.4
EV-to-EBITDA -0.41
EV-to-Revenue 1.67
EV-to-FCF -6.02
Earnings Yield (Greenblatt) % -250.14
FCF Yield % -22.84

Financials (Next Earnings Date:2024-08-15 Est.)

TSX:SZLS's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

StageZero Life Sciences Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 4.046
EPS (TTM) (C$) -0.167
Beta -0.05
Volatility % 38.44
14-Day RSI 44.25
14-Day ATR (C$) 0.001508
20-Day SMA (C$) 0.04275
12-1 Month Momentum % -43.75
52-Week Range (C$) 0.035 - 0.08
Shares Outstanding (Mil) 122.72

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

StageZero Life Sciences Ltd Filings

Filing Date Document Date Form
No Filing Data

StageZero Life Sciences Ltd Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

StageZero Life Sciences Ltd Frequently Asked Questions

What is StageZero Life Sciences Ltd(TSX:SZLS)'s stock price today?
The current price of TSX:SZLS is C$0.04. The 52 week high of TSX:SZLS is C$0.08 and 52 week low is C$0.04.
When is next earnings date of StageZero Life Sciences Ltd(TSX:SZLS)?
The next earnings date of StageZero Life Sciences Ltd(TSX:SZLS) is 2024-08-15 Est..
Does StageZero Life Sciences Ltd(TSX:SZLS) pay dividends? If so, how much?
StageZero Life Sciences Ltd(TSX:SZLS) does not pay dividend.

Press Release

Subject Date
No Press Release